Medical Equipment

Traditional Therapy Clinics Ltd (ASX:TTC) Preliminary Final Report

🕔2/28/2017 4:04:19 PM

Traditional Therapy Clinics Ltd (ASX:TTC) is pleased to provide the Company's Preliminary Final Report for the year ended 31 December, 2016.

Read Full Article▸

MMJ PhytoTech Ltd (ASX:MMJ) Takes Significant Step Towards First Australian Sales Following Submission of Import Licence Application

🕔2/28/2017 9:29:05 AM

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that the Company's Australian distribution partner, HL Pharma Pty Ltd. has submitted its application for a medicinal cannabis import licence to the Department of Health.

Read Full Article▸

Lexaria Bioscience Corp. (CSE:LXX) Notice of Patent in Australia for Cannabinoid Infused Edibles

🕔2/28/2017 8:46:56 AM

Lexaria Bioscience Corp. (OTCMKTS:LXRP) (CSE:LXX) is pleased to announce it has received a Notice of Acceptance from the Australian Patent Office that Lexaria's Australian patent application 2015274698 has been accepted with a patent issuance date expected in June, 2017.

Read Full Article▸

MMJ PhytoTech Ltd (ASX:MMJ) Announces Harvest One Closes C$25M Placement

🕔2/23/2017 9:28:36 AM

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that Canadian-based Harvest One Capital Corp. (CVE:WON.H) has closed the previously reported (January 27, 2017) private placement, raising C$25,000,500 before costs. Pursuant to the Placement, Harvest One issued 33,334,000 Subscription Receipts at a price of C$0.75.

Read Full Article▸

Imugene Limited (ASX:IMU) Encouraging HER-Vaxx Research Published in Prestigious BMC Cancer Journal

🕔2/13/2017 11:14:52 AM

Imugene Limited (ASX:IMU) preclinical research related to HER-Vaxx (clinical name IMU-131) has been accepted and published in the prestigious journal BMC Cancer. IMU-131 is a next generation HER-2 cancer therapy using B cell peptides, which harness the body's ability to develop antibodies against the disease.

Read Full Article▸

MMJ PhytoTech Ltd (ASX:MMJ) Enters Agreement to Strengthen AUS Distribution Network

🕔2/13/2017 10:07:44 AM

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that it has entered into a binding Letter of Intent with HL Pharma Pty Ltd. for the importation and distribution of the Company's medicinal cannabis products in Australia.

Read Full Article▸

MMJ PhytoTech Ltd (ASX:MMJ) Phase 2 Clinical Trial For Treatment of Epilepsy Underway

🕔2/13/2017 8:23:49 AM

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited ("PTL"), has commenced following Health Authorities' approval, the Phase 2 clinical study into the safety and efficacy of its PTL101 capsules in treating refractory epilepsy in children.

Read Full Article▸

Banking & Finance

Read More

Oil Gas & Energy

Read More

Life Sciences

Read More

Social Media

Latest Headlines